2018 annual financial data
GT Biopharma 2018 Operating margin
GT Biopharma 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -250,069,000 USD and net income was -259,186,000 USD.
Operating cash flow was -10,677,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -250,069,000 USD
- Net income
- -259,186,000 USD
- Operating cash flow
- -10,677,000 USD